header
Maine Medicine Weekly Update: 12/24/2021

In This Issue
HAPPY HOLIDAYS FROM THE MMA
Enjoy The Holidays, Our Weekly Newsletter & Thank You For All You Do
COVID-19 CORNER
FDA Updates: Pfizer & Merck Oral Antivirals Authorized; Omicron & Monoclonal Antibodies
Maine CDC Updates & Guidance
Reminder: Everyone Ages 16 and Older Can Get a Booster Shot
US CDC Reduces Time for Health Care Workers to Isolate & Updates School Guidelines
English Study: Booster Shots Protect Against Omicron for About 10 Weeks
Patients Vaccinated for COVID-19 Have Shorter Hospital Stays Than Unvaccinated Patients
JAMA Internal Medicine - Illness Severity With SARS-CoV-2 Infection, Delta vs Beta Variant
US Supreme Court to Take Up Federal COVID-19 Vaccine Rules
WHAT'S NOT COVID RELATED
CDC: Physicians Should Discuss Meds to Reduce HIV Risk
HHS: $48 Million Available to Increase the Public Health Workforce in Rural and Tribal Communities
MaineCare: Payment Cycle Reminder: Christmas and New Year's Day Holidays
IN THE NEWS
Medicine in the Media
Walgreens Pharmacy Hours Change: Call Ahead Before Picking Up Your Medication
MAINE MEDICAL ASSOCIATION JOB OPPORTUNITY
Maine Medical Education Trust (MMET) CME Program Coordinator
HEALTH COVERAGE
Open Enrollment For 2022 Individual Health Plans
UPCOMING EVENTS
Upcoming Specialty Society Meetings
Governorís Opioid Response Seminar Webinar Series Continues (Jan 7)
HEALTHCARE EMPLOYMENT OPPORTUNITIES
Psychiatric Nurse Practitioner (PNP) - Greater Portland Health
Transformational OB/GYN or Maternal Fetal Medicine Physician leader

 
Search Back Issues



 

 

 


Follow Us:
WHAT'S NOT COVID RELATED

CDC: Physicians Should Discuss Meds to Reduce HIV Risk

The CDC has recommended that primary care physicians talk to all sexually active patients about prophylactic medications that can lessen HIV transmission risk. Pre-exposure prophylaxis, or PrEP, can be 99% effective in reducing risk.

Key Takeaways

The Centers for Disease Control and Prevention (CDC) is now recommending that physicians discuss prophylactic drugs that reduce the risk of HIV transmission (PrEP) with all of their patients who are sexually active.  

A brief discussion of a patient’s sexual history should be part of primary care and should guide physicians in discussing whether patients might need PrEP.

Many physicians skip taking a sexual history of patients—either because of their own or their patients’ discomfort. As a result, patients who could benefit from PrEP miss out on key HIV prevention measures.

verywellhealth.com – CDC: All Sexually Active Patients Should Know About HIV Prevention Drugs

US CDC – Pre-Exposure Prophylaxis (PrEP), Quick Guide: 2021 PrEP Update, Clinicians’ Quick Guide

< Previous Article | Next Article >

[ return to top ]

To ensure delivery of Maine Medicine Weekly Update,
please add 'info@mainemed.com' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details: http://www.commpartners.com/website/white-listing.htm


Unsubscribe here

For more information or to contact us directly, please visit www.mainemed.com | ©